We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.02%
3 Healthcare 14.17%
4 Industrials 13.83%
5 Financials 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLCA
1076
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$125K 0.02%
+17,863
New +$77.6K
ACIC icon
1077
American Coastal Insurance
ACIC
$489M
$124K 0.02%
+21,672
New +$110K
CERS icon
1078
Cerus
CERS
$468M
$122K 0.02%
17,601
-56,971
-76% -$374K
NBRV
1079
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$122K 0.02%
+2,022
New +$219K
COTY icon
1080
Coty
COTY
$2.46B
$119K 0.02%
17,018
-6,341
-27% -$32.7K
NBLX
1081
DELISTED
Noble Midstream Partners LP
NBLX
$119K 0.02%
+11,384
New +$106K
PBR.A icon
1082
Petrobras Class A
PBR.A
$104B
$118K 0.02%
+10,700
New +$93.5K
TISI icon
1083
Team
TISI
$78.2M
$117K 0.02%
+1,071
New +$88.1K
CFMS
1084
DELISTED
Conformis, Inc. Common Stock
CFMS
$116K 0.02%
+7,048
New +$122K
PCYO icon
1085
Pure Cycle
PCYO
$263M
$114K 0.02%
+10,156
New +$101K
CCRN
1086
DELISTED
Cross Country Healthcare
CCRN
$112K 0.02%
+12,622
New +$103K
CYH icon
1087
Community Health Systems
CYH
$417M
$112K 0.02%
15,128
-84,904
-85% -$601K
ANH
1088
DELISTED
Anworth Mortgage Asset Corporation
ANH
$111K 0.02%
41,111
+9,569
+30% +$19.9K
SCYX icon
1089
SCYNEXIS
SCYX
$52.2M
$110K 0.02%
1,796
-858
-32% -$40.2K
MFIC icon
1090
MidCap Financial Investment
MFIC
$793M
$107K 0.02%
+10,028
New +$97.3K
OPK icon
1091
Opko Health
OPK
$1.02B
$107K 0.02%
26,987
-185,326
-87% -$774K
TRAW icon
1092
Traws Pharma
TRAW
$8.35M
$106K 0.02%
+608
New +$70.6K
EGIO
1093
DELISTED
Edgio, Inc. Common Stock
EGIO
$105K 0.02%
661
-288
-30% -$52.6K
TEF
1094
DELISTED
Telefonica
TEF
$104K 0.02%
+28,949
New +$97.9K
OBSV
1095
DELISTED
ObsEva SA Ordinary Shares
OBSV
$104K 0.02%
50,222
+34,957
+229% +$75.7K
ATXS
1096
DELISTED
Astria Therapeutics
ATXS
$101K 0.02%
+7,847
New +$140K
ENZ
1097
DELISTED
Enzo Biochem, Inc.
ENZ
$101K 0.02%
40,172
-26,500
-40% -$57.7K
VUZI icon
1098
Vuzix
VUZI
$227M
$100K 0.02%
+11,000
New +$54.9K
USAK
1099
DELISTED
USA Truck Inc
USAK
$100K 0.02%
11,230
-2,401
-18% -$22.5K
CLVS
1100
DELISTED
Clovis Oncology, Inc.
CLVS
$99K 0.02%
+20,706
New +$105K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.